Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis.

Photodynamic therapy is a promising new strategy in the treatment of cardiovascular diseases. Photodynamic therapy for vascular diseases may be improved by the specific delivery of photosensitizers to the atherosclerotic lesion. In this study, we studied whether oxidatively modified low-density lipoprotein (OxLDL) could be used as a specific carrier for photosensitizers, thereby using the scavenger receptor expressed on macrophages as a target. The photosensitizer aluminum phthalocyanine chloride (AlPc) was incorporated into OxLDL, and its photodynamic effects were studied. Macrophages (RAW 264.7) were incubated with various concentrations of OxLDL-AlPc for different periods. After illumination of the cells with red light, cytotoxicity was observed that was dependent on the time of illumination and incubation. Macrophages incubated with OxLDL-AlPc that were not illuminated revealed no cytotoxicity. The uptake of the OxLDL-AlPc complexes was mediated by scavenger receptors expressed on macrophages. In the presence of the polyanion polyinosinic acid, a specific ligand for scavenger receptors, no cytotoxicity could be observed. Serum incubations of the OxLDL-AlPc complexes revealed that these complexes stay intact after incubation. No redistribution of AlPc to other plasma (lipo-) proteins could be detected, and 80-90% of the AlPc remained associated with the OxLDL particle. These results indicate that OxLDL may function as a specific delivery system for photosensitizers to the scavenger receptors expressed on the macrophages in the atherosclerotic lesion, increasing the beneficial effects of photodynamic therapy for cardiovascular diseases.

[1]  A. Richter,et al.  In vitro AND in vivo UPTAKE OF BENZOPORPHYRIN DERIVATIVE INTO HUMAN AND MINISWINE ATHEROSCLEROTIC PLAQUE , 1993, Photochemistry and photobiology.

[2]  T. Kodama,et al.  Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. , 1992, The American journal of pathology.

[3]  L. Machan,et al.  Photodynamic therapy for atherosclerotic stenoses in Yucatan miniswine. , 1994, Canadian journal of surgery. Journal canadien de chirurgie.

[4]  G. Jori,et al.  Targeting of experimentally induced atherosclerotic lesions by liposome-delivered Zn(II)-phthalocyanine. , 1993, Atherosclerosis.

[5]  A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[7]  M. Brown,et al.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.

[8]  Steven K. Clinton,et al.  The role of macrophages in atherogenesis , 1993 .

[9]  U. Goldbourt,et al.  Preferential uptake of a water-soluble phthalocyanine by atherosclerotic plaques in rabbits. , 1990, Atherosclerosis.

[10]  R. Maranhão,et al.  Metabolism of protein-free lipid emulsion models of chylomicrons in rats. , 1985, Biochimica et biophysica acta.

[11]  M. Bruzelius,et al.  Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[12]  C. E. West,et al.  Separation of plasma lipoproteins by density-gradient ultracentrifugation. , 1975, Analytical biochemistry.

[13]  H. Lodish,et al.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.

[14]  H. Aburatani,et al.  Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. McEwan,et al.  Photodynamic therapy of normal and balloon-injured rat carotid arteries using 5-amino-levulinic acid. , 1995, Circulation.

[16]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[17]  M. Freeman,et al.  Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils , 1990, Nature.

[18]  H. Esterbauer,et al.  Biochemical, structural, and functional properties of oxidized low-density lipoprotein. , 1990, Chemical research in toxicology.

[19]  D. Steinberg,et al.  Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. V. van Berkel,et al.  Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. , 1997, Journal of lipid research.

[21]  M. Alessio,et al.  Synthesis, Processing, and Intracellular Transport of CD36 during Monocytic Differentiation (*) , 1996, The Journal of Biological Chemistry.

[22]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[23]  P Baas,et al.  Photodynamic therapy: a promising new modality for the treatment of cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.

[24]  A. Mcfarlane,et al.  Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.

[25]  D. Steinberg,et al.  The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[27]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins. , 1972, Biochimica et biophysica acta.

[28]  R. Silverstein,et al.  Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[29]  J. Schneider,et al.  Application of photodynamic therapy to the treatment of atherosclerotic plaques. , 1993, Neurosurgery.

[30]  G. Buonaccorsi,et al.  Inhibition of intimal hyperplasia in balloon injured arteries with adjunctive phthalocyanine sensitised photodynamic therapy. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[31]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Brown,et al.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Yamashita,et al.  Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. , 1995, The Journal of clinical investigation.

[34]  Levy Jg,et al.  Photosensitizers in photodynamic therapy. , 1994 .

[35]  Anil K. Jain,et al.  Delivery of Benzoporphyrin Derivative, a Photosensitizer, into Atherosclerotic Plaque of Watanabe Heritable Hyperlipidemic Rabbits and Balloon‐Injured New Zealand Rabbits , 1997, Photochemistry and photobiology.

[36]  D. Steinberg,et al.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. , 1991, The Journal of clinical investigation.